CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase Ib/II Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06022757
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:56.900002+00:00
Published At: 2024-02-23T00:00:00+00:00
Record Updated At: 2024-02-23
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Carcinoma", "Squamous Cell Carcinoma of Head and Neck", "Urothelial Carcinoma", "Prostate Cancer", "Small-cell Lung Cancer", "Non-small Cell Lung Cancer", "Cervical Cancer", "Other Solid Tumors"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-02-23"
protocolSection.identificationModule.nctId: "NCT06022757"
protocolSection.identificationModule.officialTitle: "A Phase Ib/II Study of XNW5004 Tablet in Combination With KEYTRUDA\u00ae (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19)"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.